Jiangsu Wuzhong Industrial Co Ltd (600200) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jiangsu Wuzhong Industrial Co Ltd (600200) has a cash flow conversion efficiency ratio of -0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-9.38 Million ≈ $-1.37 Million USD) by net assets (CN¥1.81 Billion ≈ $264.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Jiangsu Wuzhong Industrial Co Ltd's balance sheet to measure how much of total assets are equity-financed.
Jiangsu Wuzhong Industrial Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how Jiangsu Wuzhong Industrial Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Jiangsu Wuzhong Industrial Co Ltd (600200) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Jiangsu Wuzhong Industrial Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jiangsu Wuzhong Industrial Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Systech Bhd
KLSE:0050
|
1.187x |
|
Enjoei S.A
SA:ENJU3
|
0.112x |
|
Rand Capital Corp
NASDAQ:RAND
|
0.009x |
|
Optrontec Inc
KQ:082210
|
0.098x |
|
GP Petroleums Limited
NSE:GULFPETRO
|
0.039x |
|
Malmbergs Elektriska AB (publ)
ST:MEAB-B
|
-0.016x |
|
V-Tac Technology Co Ltd
TWO:6229
|
-0.138x |
|
Urban One Inc Class D
NASDAQ:UONEK
|
-0.002x |
Annual Cash Flow Conversion Efficiency for Jiangsu Wuzhong Industrial Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of Jiangsu Wuzhong Industrial Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see 600200 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.89 Billion ≈ $276.42 Million |
CN¥-274.65 Million ≈ $-40.19 Million |
-0.145x | -25.74% |
| 2023-12-31 | CN¥1.76 Billion ≈ $257.75 Million |
CN¥-203.68 Million ≈ $-29.80 Million |
-0.116x | -474.71% |
| 2022-12-31 | CN¥1.82 Billion ≈ $266.85 Million |
CN¥56.27 Million ≈ $8.23 Million |
0.031x | -87.06% |
| 2021-12-31 | CN¥1.88 Billion ≈ $274.65 Million |
CN¥447.64 Million ≈ $65.50 Million |
0.238x | +206.54% |
| 2020-12-31 | CN¥1.85 Billion ≈ $270.98 Million |
CN¥-414.56 Million ≈ $-60.66 Million |
-0.224x | -218.66% |
| 2019-12-31 | CN¥2.36 Billion ≈ $345.83 Million |
CN¥-166.03 Million ≈ $-24.30 Million |
-0.070x | -150.65% |
| 2018-12-31 | CN¥2.41 Billion ≈ $352.38 Million |
CN¥334.03 Million ≈ $48.88 Million |
0.139x | +63.21% |
| 2017-12-31 | CN¥2.93 Billion ≈ $428.95 Million |
CN¥249.14 Million ≈ $36.46 Million |
0.085x | -63.62% |
| 2016-12-31 | CN¥2.97 Billion ≈ $434.37 Million |
CN¥693.45 Million ≈ $101.47 Million |
0.234x | +867.17% |
| 2015-12-31 | CN¥1.70 Billion ≈ $249.06 Million |
CN¥41.11 Million ≈ $6.02 Million |
0.024x | +108.66% |
| 2014-12-31 | CN¥1.14 Billion ≈ $166.62 Million |
CN¥-317.70 Million ≈ $-46.49 Million |
-0.279x | -229.59% |
| 2013-12-31 | CN¥1.07 Billion ≈ $156.24 Million |
CN¥229.89 Million ≈ $33.64 Million |
0.215x | -50.47% |
| 2012-12-31 | CN¥1.01 Billion ≈ $147.57 Million |
CN¥438.42 Million ≈ $64.15 Million |
0.435x | +235.83% |
| 2011-12-31 | CN¥1.01 Billion ≈ $147.77 Million |
CN¥-323.20 Million ≈ $-47.29 Million |
-0.320x | -889.30% |
| 2010-12-31 | CN¥992.24 Million ≈ $145.20 Million |
CN¥-32.10 Million ≈ $-4.70 Million |
-0.032x | -116.52% |
| 2009-12-31 | CN¥889.76 Million ≈ $130.20 Million |
CN¥174.23 Million ≈ $25.50 Million |
0.196x | +476.07% |
| 2008-12-31 | CN¥875.40 Million ≈ $128.10 Million |
CN¥29.76 Million ≈ $4.35 Million |
0.034x | +144.44% |
| 2007-12-31 | CN¥862.84 Million ≈ $126.26 Million |
CN¥-66.00 Million ≈ $-9.66 Million |
-0.076x | -238.03% |
| 2006-12-31 | CN¥970.89 Million ≈ $142.07 Million |
CN¥53.80 Million ≈ $7.87 Million |
0.055x | -0.10% |
| 2005-12-31 | CN¥991.76 Million ≈ $145.13 Million |
CN¥55.01 Million ≈ $8.05 Million |
0.055x | -69.17% |
| 2004-12-31 | CN¥949.96 Million ≈ $139.01 Million |
CN¥170.90 Million ≈ $25.01 Million |
0.180x | +4276.31% |
| 2003-12-31 | CN¥895.88 Million ≈ $131.10 Million |
CN¥-3.86 Million ≈ $-564.70K |
-0.004x | -115.74% |
| 2002-12-31 | CN¥837.35 Million ≈ $122.53 Million |
CN¥22.91 Million ≈ $3.35 Million |
0.027x | +160.71% |
| 2001-12-31 | CN¥770.71 Million ≈ $112.78 Million |
CN¥-34.74 Million ≈ $-5.08 Million |
-0.045x | -125.46% |
| 2000-12-31 | CN¥445.11 Million ≈ $65.13 Million |
CN¥78.79 Million ≈ $11.53 Million |
0.177x | +1411.98% |
| 1999-12-31 | CN¥403.37 Million ≈ $59.03 Million |
CN¥-5.44 Million ≈ $-796.34K |
-0.013x | -112.46% |
| 1998-12-31 | CN¥122.72 Million ≈ $17.96 Million |
CN¥13.29 Million ≈ $1.94 Million |
0.108x | -- |
About Jiangsu Wuzhong Industrial Co Ltd
JiangSu WuZhong Pharmaceutical Development Co., Ltd. engages in pharmaceutical, medical cosmetology, investment, and other industries in China and internationally. It provides genetic and chemical drugs in the fields of anti-virus, anti infection, immune regulation, anti-tumor, digestive system, cardiovascular, etc.; and modern traditional Chinese medicine. The company also offers high-end inject… Read more